ADC Therapeutics SA - notizie pubblicate 183 - letture 4.612


ADC Therapeutics SA

ADC THERAPEUTICS SA

Preliminary Proxy Statement - Form PRE 14A

United states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1934 (amendment no. ...

13.09.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

View all news adc therapeutics makes grants to new employees under inducement plan september 03, 2024 lausanne, switzerland, sept. 03, 2024 (globe newswire) -- adc therapeutics sa ...

03.09.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics to Present at Upcoming Investor Conferences

View all news adc therapeutics to present at upcoming investor conferences september 03, 2024 lausanne, switzerland, sept. 03, 2024 (globe newswire) -- adc therapeutics sa (nyse: a ...

03.09.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Notice of Effectiveness - Form EFFECT

Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: august 13, 2024 4:00 p.m. form: s-3 cik: ...

14.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Registration Statement Specified Transactions Form S 3

As filed with the securities and exchange commission on august 6, 2024. registration no. 333- united states securities and exchange commission washington, d.c. 20549 form s-3 regis ...

06.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Quarterly Report for Quarter Ending June 30, 2024 (Form 10-Q)

Adc-20240630 table of contents united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of ...

06.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

2Q 2024 Earnings Call Presentation

2q 2024 earnings call august 6, 2024 agenda q&a ameet mallik business update chief executive officer pepe carmona financial update chief financial officer 2 forward-looking sta ...

06.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update Form 8 K

Adc therapeutics reports second quarter 2024 financial results and provides operational update zynlonta® net sales of $17.0 million in 2q 2024; commercial profitability achieved d ...

06.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

View all news adc therapeutics reports second quarter 2024 financial results and provides operational update august 06, 2024 zynlonta® net sales of $17.0 million in 2q 2024; comme ...

06.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

View all news adc therapeutics makes grants to new employees under inducement plan august 01, 2024 lausanne, switzerland, aug. 01, 2024 (globe newswire) -- adc therapeutics sa (nys ...

01.08.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024

View all news adc therapeutics to host second quarter 2024 financial results conference call on august 6, 2024 july 30, 2024 lausanne, switzerland, july 30, 2024 (globe newswire) - ...

30.07.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

19.06.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

19.06.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

19.06.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

19.06.2024
Condividi